Clinical Trial Update: Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial update describing the risk of stroke and silent cerebrovascular thromboembolism after cardioversion in patients with atrial fibrillation; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Snippet

Sponsor: Suleyman Demirel University | Conditions: Atrial Fibrillation, Cardioversion | Phase 3 | Status: COMPLETED | Results posted: 2024-10-08